Overview

Single Ascending Dose Study of RBP-7000

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the safety and tolerability of injections of RBP-7000 in subjects with stable schizophrenia
Phase:
Phase 1
Details
Lead Sponsor:
Indivior Inc.
Treatments:
Risperidone